Td Waterhouse Canada Inc. Ab Cellera Biologics Inc. Transaction History
Td Waterhouse Canada Inc.
- $13.3 Trillion
- Q1 2024
A detailed history of Td Waterhouse Canada Inc. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 258,322 shares of ABCL stock, worth $1.01 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
258,322
Previous 258,130
0.07%
Holding current value
$1.01 Million
Previous $1.58 Billion
28.07%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ABCL
# of Institutions
171Shares Held
120MCall Options Held
264KPut Options Held
254K-
Baker Bros. Advisors LP New York, NY27.5MShares$108 Million1.58% of portfolio
-
Baillie Gifford & CO23.2MShares$90.9 Million0.08% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$41.7 Million0.06% of portfolio
-
Capital World Investors Los Angeles, CA8.35MShares$32.7 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$17.8 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.12B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...